ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in securities by Directors and by Directors of major subsidiaries

Dealing in securities by Directors and by Directors of major subsidiaries

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")


DEALING IN SECURITIES BY DIRECTORS AND BY DIRECTORS OF A MAJOR
SUBSIDIARY

In compliance with paragraph 3.63 of the Listings Requirements of the
JSE Limited, disclosure is made of the following information:

Deferred bonus shares have vested in respect of the Aspen South
African Management Deferred Incentive Scheme as accepted by directors
of the Company and directors of a major subsidiary of the Company in
2010 and which they continue to hold.

BY DIRECTORS OF THE COMPANY:

Director                           :   Michael Guy Attridge
Company                            :   Aspen Pharmacare Holdings Limited
Date of transaction                :   18 November 2013
Number of shares sold to pay tax   :   8 359
Value of shares sold on market     :   R2 229 596.07
Selling price                      :   R266.73
Shares retained                    :   11 231
Value of shares retained           :   R2 995 644.63
Class of securities                :   Ordinary shares
Nature of interest                 :   Direct beneficial
Clearance obtained                 :   Yes

BY DIRECTORS OF THE COMPANY:
Director                           :   Stephen Bradley Saad
Company                            :   Aspen Pharmacare Holdings Limited
Date of transaction                :   18 November 2013
Shares delivered                   :   23 698
Value of shares delivered          :   R6 320 967.54
Class of securities                :   Ordinary shares
Nature of interest                 :   Direct beneficial
Clearance obtained                 :   Yes

BY DIRECTORS OF A MAJOR SUBSIDIARY:
Director                          :    Sean Matthew Capazorio
Company                           :    Pharmacare Limited
Date of transaction               :    18 November 2013
Number of shares sold to pay tax :     3 262
Value of shares sold on market    :    R870 073.26
Selling price                     :    R266.73
Shares retained                   :    4 382
Value of shares retained          :    R1 168 810.86
Class of securities               :    Ordinary shares
Nature of interest                :    Direct beneficial
Clearance obtained                :    Yes

Director                           :   Mziwandile Noel Guliwe
Company                            :   Pharmacare Limited
Date of transaction                :   18 November 2013
Number of shares sold to pay tax   :   4 300
Value of shares sold on market     :   R1 146 939.00
Selling price                      :   R266.73
Shares retained                    :   6 014
Value of shares retained           :   1 604 114.22
Class of securities                :   Ordinary shares
Nature of interest                 :   Direct beneficial
Clearance obtained                 :   Yes

Director                           :   Morne Geyser
Company                            :   Pharmacare Limited
Date of transaction                :   18 November 2013
Number of shares sold to pay tax   :   2 564
Value of shares sold on market     :   R683 895.72
Selling price                      :   R266.73
Shares retained                    :   3 586
Value of shares retained           :   R956 493.78
Class of securities                :   Ordinary shares
Nature of interest                 :   Direct beneficial
Clearance obtained                 :   Yes

Durban
19 November 2013

Sponsor
Investec Bank Limited

Date: 19/11/2013 04:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.